Propagation and control of T cell responses by heparan sulfate-bound IL-2

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5470-5474

  Wrenshall, Lucile E ^a   Platt, Jeffrey L ^b   Stevens, Elliot T ^a   Wight, Thomas N ^c   Miller, John D ^a,c  

^a NEBRASKA MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c Hope Heart Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0038189732     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5470     Document Type: Article

References (29)

1. Kasakura, S., and L. Lowenstein. 1965. A factor stimulating DNA synthesis derived form the medium of leucocyte cultures. Nature 20:462.
2. Smith, K. A., C. Beadling, and E. L. Jacobson. 1999. Interleukin-2. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin and R. Snyderman, eds. Lippincott Williams & Wilkins, Philadelphia, PA, p. 463.
3. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007.
4. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
5. Smith K. A., M. F. Favata, and S. Oroszlan. 1983. Production and characterization of monoclonal antibodies to human interleukin-2: strategy and tactics. J. Immunol. 131:1808.
6. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced call death. Immunity 11:28.
7. Lenardo, M. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
8. 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157:4309.
9. Wrenshall, L. E., and J. L. Platt. 1999. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163:3793.
10. Somasundaram, R., M. Ruehl, N. Tiling, R. Ackermann, M. Schmid, E. O. Riecken, and D. Schuppan. 2000. Collagens serve as an extracellular store of bioactive interleukin 2. J. Biol. Chem. 275:38170.
11. Najjam, S., B. Mulloy, J. Theze, M. Gordon, R. Gibbs, and C. Rider. 1998. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites. Glycobiology 8:509.
12. Ihrcke, N., and J. Platt. 1996. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell. Physiol. 166:625.
13. Sekiguchi, R. T., S. Potter-Perigo, K. Braun, J. Miller, C. Ngo, K. Fukuchi, T. N. Wight, K. Kimata, and A. D. Snow. 1994. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. J. Neurosci. Res. 38:670.
14. Kearney, E. K., D. L. Pape, and M. Jenkins. 1994. Visualization of peptidespecific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
15. Reinhardt, R. L., A. Khoruts, R. Merica, T. Zell, and M. K. Jenkins. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101.
16. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261.
17. Khoruts, A., A. Mondino, K. Pape, S. Reiner, and M. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187:225.
18. Smith, K. A., and D. A. Cantrell. 1985. Interleukin 2 regulates its own receptors. Proc. Natl. Acad. Sci. USA 82:864.
19. Li, X. C., G. Demirci, S. Ferrari-Lacraz, C. Groves, A. Coyle, T. R. Malek, and T. B. Strom. 2002. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat. Med. 7:114.
20. Fukushima, K., S. Hara-Kuge, H. Ideo, and K. Yamashita. 2001. Carbohydrate recognition site of interleukin-2 in relation to cell proliferation. J. Biol. Chem. 276:31202.
21. Chang, D. Z., Z. Wu, and T. L. Ciardelli. 1996. A point mutation in interleukin-2 that alters ligand internalization. J. Biol. Chem. 271:13349.
22. + subsets. Cell. Immunol. 182:152.
23. Anderson, P., and M. Sorenson. 1994. Effects of route and formulation on clinical pharmacokinetics of interleukin-2. Clin. Pharmacokinet. 27:19.
24. Hovingh, P., M. Piepkorn, and A. Linker. 1986. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate hepatitis and heparan sulphates. Biochem. J. 237:573.
25. Toida, T., H. Yoshida, H. Toyoda, I. Koshiishi, T, Imanari, R. Hileman, J. Fromm, and R. Linhardt. 1997. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem. J. 322:499.
26. Liu, D., Z. Shriver, G. Venkataraman, Y. El Shabrawi, and R. Sasisekharan. 2002. Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 99:568.
27. Podolin, P. L., M. B. Wilusz, R. M. Cubbon, U. Pajvani, C. J. Lord, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 2000. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12:477.
28. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413.
29. Aoki, K., M. Kurooka, J. J. Chen, J. Petryniak, E. G. Nabel, and G. J. Nabel. 2001. Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat. Immunol. 2:333.